Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N0ME
|
||||
Former ID |
DNC010620
|
||||
Drug Name |
4-benzhydryl-N-butylpiperazine-1-carboxamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530617] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H29N3O
|
||||
Canonical SMILES |
CCCCNC(=O)N1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3
|
||||
InChI |
1S/C22H29N3O/c1-2-3-14-23-22(26)25-17-15-24(16-18-25)21(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,21H,2-3,14-18H2,1H3,(H,23,26)
|
||||
InChIKey |
QRGYLEAVFDZUPV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Inhibitor | [530617] | |
Cannabinoid receptor 1 | Target Info | Inhibitor | [530617] | ||
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.